The treatment landscape for hematologic malignancies—cancers of the blood, bone marrow, and lymphatic system—has been revolutionized by the advent of cell-based cancer immunotherapy. This innovative approach, with chimeric antigen receptor (CAR) T-cell therapy at its forefront, has provided a powerful new weapon against diseases like leukemia, lymphoma, and multiple...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek